Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation

Clinical trial NCT07628062 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07628062
Sponsor: ImmunityBio, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HPV-Positive Oropharyngeal Squamous Cell Carcinoma Oropharyngeal Squamous Cell Carcinoma Head and Neck Cancer

Start date: 2026-07-22
Primary completion: 2030-12-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.